SCHEMBL296273

SCHEMBL296273

CC(C)(F)[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL296274 1.00
SCHEMBL11685771 1.00
Hydrochloric Acid SCHEMBL11684187 0.97 ALDH1A1 (0.54)
Valine SCHEMBL18301545 0.87 SLC7A5 (0.62)
Valine SCHEMBL18301544 0.87 SLC7A5 (0.62)
SCHEMBL13227969 0.83
SCHEMBL5299472 0.83
SCHEMBL23093886 0.79 ALDH1A1 (0.52)
SCHEMBL21688194 0.79 ALDH1A1 (0.52)
SCHEMBL18774926 0.79 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116365044-A Electrolyte, secondary battery and electric equipment 欣旺达电动汽车电池有限公司 2023-06-30 CN claimed
US-11680088-B2 Bioactive peptides derived from snakes UNIVERSITEIT LEIDEN (NL) 2023-06-20 US claimed
EP-2994154-B1 ANTIMICROBIAL PEPTIDE ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2020-02-26 EP claimed
US-20190016766-A1 Use of improved modulators of complement function as cancer therapeutics BENJAMIN DANIEL E (US) 2019-01-17 US claimed
US-20180369328-A1 Modulators of Complement Function FRITZINGER DAVID C (US) 2018-12-27 US claimed
US-10130677-B2 Antimicrobial peptide and uses thereof ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC (NL) 2018-11-20 US claimed
EP-3087092-B1 ANTIMICROBIAL PEPTIDE AND USES THEREOF ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2018-07-25 EP claimed
EP-3335720-A1 C-DI-GMP BINDING PEPTIDES Universität Basel (CH) 2018-06-20 EP claimed
WO-2017060891-A1 MODULATORS OF COMPLEMENT FUNCTION FRITZINGER DAVID C (US) 2017-04-13 WO claimed
US-20160317611-A1 Antimicrobial Peptide and Uses Thereof ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC (NL) 2016-11-03 US claimed
CN-116507617-B 1- (2- (4-Cyclopropyl-1H-1, 2, 3-triazol-1-yl) acetyl) -4-hydroxypyrrolidine-2-carboxamide derivatives as VHL inhibitors 基因泰克公司 2026-05-22 CN disclosed
EP-4729094-A2 Modulators of complement activity UCB Holdings, Inc. (US) 2026-04-22 EP disclosed
EP-4727655-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP disclosed
EP-4727653-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP disclosed
EP-4727654-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP disclosed
WO-1998058915-A2 PYRIMIDIN-2,4,6-TRION DERIVATIVES AND THEIR USE AS METALLOPROTEASE-INHIBITORS ROCHE DIAGNOSTICS GMBH (DE) 1998-12-30 WO disclosed
US-5780505-A ADMINISTERING AS SMOOTH MUSCLE RELAXANT AMERICAN HOME PRODUCTS CORPORATION (US) 1998-07-14 US disclosed
US-5763474-A SMOOTH MUSCLE RELAXANTS AMERICAN HOME PRODUCTS CORPORATION (US) 1998-06-09 US disclosed
WO-1998002413-A1 SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AMERICAN HOME PRODUCTS CORPORATION (US) 1998-01-22 WO disclosed
US-4049708-A Fluorodesulfurization of alkyl mercaptans or alkyl dithianes MERCK & CO., INC. (US) 1977-09-20 US disclosed